🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07693283
Recruiting Observational

Expression of Target in Endometriotic Lesions

NCT07693283 · tracked via the Priya Life Science China tracker
Sponsor
Beijing Tsinghua Chang Gung Hospital
Phase
Observational
Started
2026-04-13
Last updated
2026-07-09

Condition(s) studied

Endometriosis

Investigational drug(s) / intervention(s)

Retrospective molecular expression analysis in endometriosis tissue specimens

Retrospective molecular expression analysis in endometriosis tissue specimens: This study involves no prospective interventional measures for participants.

Study summary

Endometriosis is a common gynecological disorder associated with chronic pelvic pain and infertility, which affects women of reproductive age worldwide. This study aims to investigate the expression patterns of specific molecules in tissue specimens obtained from patients with endometriosis. The investigators will compare the expression levels of these molecules between endometriotic lesions and normal tissue. The primary objective of this study is to elucidate the potential roles of these molecules in the pathogenesis of endometriosis.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria: * Pathologically confirmed endometriosis via laparoscopy and histopathological examination * Complete clinical and pathological data available Exclusion Criteria: • History of any malignant tumor

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Beijing Tsinghua Changgung Hospital Beijing Beijing Municipality Recruiting

More Beijing Tsinghua Chang Gung Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07693283 on ClinicalTrials.gov ↗ ← All trials in China